Ian Muir Anderson

机构：Emory University, University of Manchester, South Eastern Sydney Local Health District, University of Glasgow · ORCID：0000-0003-2205-9209

发表论文 796 篇 · 总被引 25363 次 · h-index 78

代表论文

• A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials (2021 · Molecular Psychiatry · 被引 213)
• Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 158)
• Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study (2024 · The Lancet Oncology · 被引 118)
• The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression (2022 · CNS Spectrums · 被引 76)
• Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo (2024 · Nature Mental Health · 被引 44)
• Seminars in General Adult Psychiatry (2024 · Cambridge University Press eBooks · 被引 41)